RoosterBio had the honor to discuss MSCs and cell therapy with Dr. Christian van den Bos, founder and owner of Mares Ltd. Dr. van den Bos provided his perspective on ... More

Dr. Steven Jay is an associate professor in the Fischell Department of Bioengineering at the University of Maryland, whose research focuses on design and development of novel biotherapeutics, including extracellular ... More

Know Your COGs Webinar Recap Commercializing a living cellular product can be a very daunting endeavor for any cell therapy product developer. It is a complex process that requires good ... More

In this “MSC Rising Star” interview, we talked to Dr. Rebekah Samsonraj to learn more about her research and passion in understanding stem cell potency and aging of mesenchymal stromal ... More

Paracrine signaling is a form of cell-to-cell communication that has been observed to be responsible for the regenerative power of many cell-based therapies such as mesenchymal stromal cells (MSCs). To ... More

Whether Upstream or Downstream,  EV Manufacturing is Becoming Seaworthy in 2020 Manufacturing and Isolation Methods After exploring the Conference’s highlights (Part I) with basic biology, applied technologies and clinical translation, ... More

To Harness Heterogeneity, Extracellular Vesicle (EV) Differences Explored with Deference Above, a rudimentary mind-map showing many of the topics on display at 2020’s virtual Annual ISEV Meeting.  A major theme ... More

Is your product screwed, do you have it in the bag, or is it time to consider something new? Disclosure Statement: RoosterBio has no financial affiliation with any of the ... More

Above, diagram of the hypothesized role of MSCs to disrupt the cycle of neutrophil “NETosis” in COVID-19 lung damage, via its immunomodulatory paracrine activity on Tregs and macrophages. Could human ... More

How hMSCs Could Work in Patients, What Are Their Biomanufacturing Needs, and When Can They Be Safely Stockpiled? On New Year’s Day, 2020, buried in the headlines was news of a ... More